These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30628448)

  • 21. The nanoparticle protein corona formed in human blood or human blood fractions.
    Lundqvist M; Augustsson C; Lilja M; Lundkvist K; Dahlbäck B; Linse S; Cedervall T
    PLoS One; 2017; 12(4):e0175871. PubMed ID: 28414772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endosomal sorting results in a selective separation of the protein corona from nanoparticles.
    Han S; da Costa Marques R; Simon J; Kaltbeitzel A; Koynov K; Landfester K; Mailänder V; Lieberwirth I
    Nat Commun; 2023 Jan; 14(1):295. PubMed ID: 36653346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved In Vitro and In Vivo Biocompatibility of Graphene Oxide through Surface Modification: Poly(Acrylic Acid)-Functionalization is Superior to PEGylation.
    Xu M; Zhu J; Wang F; Xiong Y; Wu Y; Wang Q; Weng J; Zhang Z; Chen W; Liu S
    ACS Nano; 2016 Mar; 10(3):3267-81. PubMed ID: 26855010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction.
    Gräfe C; Weidner A; Lühe MV; Bergemann C; Schacher FH; Clement JH; Dutz S
    Int J Biochem Cell Biol; 2016 Jun; 75():196-202. PubMed ID: 26556312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona.
    Saha K; Rahimi M; Yazdani M; Kim ST; Moyano DF; Hou S; Das R; Mout R; Rezaee F; Mahmoudi M; Rotello VM
    ACS Nano; 2016 Apr; 10(4):4421-30. PubMed ID: 27040442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stealth effect of biomolecular corona on nanoparticle uptake by immune cells.
    Caracciolo G; Palchetti S; Colapicchioni V; Digiacomo L; Pozzi D; Capriotti AL; La Barbera G; Laganà A
    Langmuir; 2015 Oct; 31(39):10764-73. PubMed ID: 26378619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation and Characterization of Protein Corona Around Nanoparticles: A Review.
    Pareek V; Bhargava A; Bhanot V; Gupta R; Jain N; Panwar J
    J Nanosci Nanotechnol; 2018 Oct; 18(10):6653-6670. PubMed ID: 29954482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring of the Enzymatic Degradation of Protein Corona and Evaluating the Accompanying Cytotoxicity of Nanoparticles.
    Ma Z; Bai J; Jiang X
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):17614-22. PubMed ID: 26200209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles Penetrate into the Multicellular Spheroid-on-Chip: Effect of Surface Charge, Protein Corona, and Exterior Flow.
    Huang K; Boerhan R; Liu C; Jiang G
    Mol Pharm; 2017 Dec; 14(12):4618-4627. PubMed ID: 29096441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silver nanoparticle protein corona and toxicity: a mini-review.
    Durán N; Silveira CP; Durán M; Martinez DS
    J Nanobiotechnology; 2015 Sep; 13():55. PubMed ID: 26337542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.
    Kang B; Okwieka P; Schöttler S; Winzen S; Langhanki J; Mohr K; Opatz T; Mailänder V; Landfester K; Wurm FR
    Angew Chem Int Ed Engl; 2015 Jun; 54(25):7436-40. PubMed ID: 25940402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hard corona composition and cellular toxicities of the graphene sheets.
    Mao H; Chen W; Laurent S; Thirifays C; Burtea C; Rezaee F; Mahmoudi M
    Colloids Surf B Biointerfaces; 2013 Sep; 109():212-8. PubMed ID: 23643918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles.
    Hadjidemetriou M; Al-Ahmady Z; Kostarelos K
    Nanoscale; 2016 Apr; 8(13):6948-57. PubMed ID: 26961355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The bio-interface between functionalized Au NR@GO nanoplatforms with protein corona and their impact on delivery and release system.
    Assali A; Razzazan S; Akhavan O; Mottaghitalab F; Adeli M; Atyabi F
    Colloids Surf B Biointerfaces; 2019 Jan; 173():891-898. PubMed ID: 30551306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Label-free in-flow detection of receptor recognition motifs on the biomolecular corona of nanoparticles.
    Gianneli M; Polo E; Lopez H; Castagnola V; Aastrup T; Dawson KA
    Nanoscale; 2018 Mar; 10(12):5474-5481. PubMed ID: 29511756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggregation and protein corona formation on gold nanoparticles affect viability and liver functions of primary rat hepatocytes.
    Koh WL; Tham PH; Yu H; Leo HL; Yong Kah JC
    Nanomedicine (Lond); 2016 Sep; 11(17):2275-87. PubMed ID: 27527273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of graphene oxide with cell culture medium: Evaluating the fetal bovine serum protein corona formation towards in vitro nanotoxicity assessment and nanobiointeractions.
    Franqui LS; De Farias MA; Portugal RV; Costa CAR; Domingues RR; Souza Filho AG; Coluci VR; Leme AFP; Martinez DST
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():363-377. PubMed ID: 30948072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZrO2 nanoparticles labeled via a native protein corona: detection by fluorescence microscopy and Raman microspectroscopy in rat lungs.
    Silge A; Bräutigam K; Bocklitz T; Rösch P; Vennemann A; Schmitz I; Popp J; Wiemann M
    Analyst; 2015 Aug; 140(15):5120-8. PubMed ID: 26087290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide.
    Hajipour MJ; Raheb J; Akhavan O; Arjmand S; Mashinchian O; Rahman M; Abdolahad M; Serpooshan V; Laurent S; Mahmoudi M
    Nanoscale; 2015 May; 7(19):8978-94. PubMed ID: 25920546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.